Trial Profile
Perioperative Chemotherapy Prior To and After Reoperation for Incidental Gallbladder Cancer - An International, Randomized Phase III Trial
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 08 Jun 2020
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Cisplatin (Primary) ; Gemcitabine (Primary)
- Indications Gallbladder cancer
- Focus Therapeutic Use
- 03 Jun 2020 Planned End Date changed from 30 Apr 2026 to 1 Jun 2020.
- 03 Jun 2020 Planned primary completion date changed from 30 Apr 2026 to 1 Jun 2020.
- 03 Jun 2020 Planned initiation date changed from 15 Mar 2019 to 3 Apr 2019.